Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 421

2.
3.

Substandard medicines in resource-poor settings: a problem that can no longer be ignored.

Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J.

Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Review.

4.

Spurious and counterfeit drugs: a growing industry in the developing world.

Gautam CS, Utreja A, Singal GL.

Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213. Review.

PMID:
19520877
5.

[Update on counterfeit drugs: a growing risk for public health].

Juillet Y.

Bull Acad Natl Med. 2008 Oct;192(7):1423-34; discussion 1434-6. Review. French.

PMID:
19445366
6.

Pharmaceutical counterfeiting.

Deisingh AK.

Analyst. 2005 Mar;130(3):271-9. Review.

PMID:
15724152
7.

[Counterfeit drugs as a gobal threat to health].

Golocorbin Kon S, Mikov M.

Med Pregl. 2011 May-Jun;64(5-6):285-90. Review. Serbian.

PMID:
21789919
8.

Drugs for neglected diseases: a failure of the market and a public health failure?

Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pécoul B.

Trop Med Int Health. 2001 Nov;6(11):945-51. Review.

9.

Conflicts of interest in research involving human beings.

Greco D, Diniz NM.

J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. Review.

PMID:
18664007
10.

[Counterfeit medicines--Japan and the world].

Sato D.

Yakugaku Zasshi. 2014;134(2):213-22. Review. Japanese.

11.

Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.

Cohen JC, Mrazek M, Hawkins L.

Clin Pharmacol Ther. 2007 Mar;81(3):445-9. Review.

PMID:
17251983
12.

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D.

Curr HIV Res. 2006 Jan;4(1):3-20. Review.

PMID:
16454707
13.

[Diagnostic kits in parasitology: which controls?].

Rossi P.

Parassitologia. 2004 Jun;46(1-2):145-9. Review. Italian.

PMID:
15305705
14.

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.

Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME.

J Antimicrob Chemother. 2007 Aug;60(2):214-36. Review.

15.

Introduction: The provision of animal health services in a changing world.

de Haan C.

Rev Sci Tech. 2004 Apr;23(1):15-32. Review. English, French, Spanish.

PMID:
15200084
16.

Understanding and fighting the medicine counterfeit market.

Dégardin K, Roggo Y, Margot P.

J Pharm Biomed Anal. 2014 Jan;87:167-75. doi: 10.1016/j.jpba.2013.01.009. Review.

PMID:
23384475
17.

Ensuring global access to quality medicines: role of the US Pharmacopeia.

USP council of convention section on global public health.; USP council of experts international health expert committee.; USP regionalization team., Heyman ML, Williams RL.

J Pharm Sci. 2011 Apr;100(4):1280-7. doi: 10.1002/jps.22391. Review.

PMID:
24081465
18.

AIDS: what does economics have to offer?

Hanson K.

Health Policy Plan. 1992 Dec;7(4):315-28. Review.

19.

Drug policy: making effective drugs available without bankrupting the healthcare system.

Laupacis A, Anderson G, O'Brien B.

Healthc Pap. 2002;3(1):12-30. Review.

PMID:
12811107
20.

Roles for pharmacy in combatting counterfeit drugs.

Ziance RJ.

J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):e71-88; quiz e89-91. doi: 10.1331/JAPhA.2008.07069. Review.

PMID:
18653407
Items per page

Supplemental Content

Support Center